| 429 |
Parthenolide
|
-
Parthenolide, CAS-RN: 20554-84-1, DTXSID2040579
|
None
|
| 632 |
Pathogen Associated Molecular Patterns (PAMPs)
|
|
377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
|
| 768 |
PCB 126
|
|
2 AOPs
|
| 685 |
Pebulate
|
-
Pebulate, CAS-RN: 1114-71-2, DTXSID8021199
|
None
|
| 152 |
Penicillin
|
|
None
|
| 600 |
Pentachlorophenol
|
-
Pentachlorophenol, CAS-RN: 87-86-5, DTXSID7021106
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 709 |
Pentamidine
|
-
Pentamidine, CAS-RN: 100-33-4, DTXSID7023431
|
None
|
| 773 |
Per- and Polyfluorinated Substances (PFAS)
|
|
529: Xenobiotic binding to peroxisome proliferator-activated receptors (PPARs) causes dysregulation of lipid metabolism leading to liver steatosis
|
| 66 |
Perchlorate
|
-
Perchlorate, CAS-RN: 14797-73-0, DTXSID6024252
|
2 AOPs
|
| 259 |
Perflourinated chemicals
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 771 |
Perfluorooctanesulfonic acid
|
-
Perfluorooctanesulfonic acid, CAS-RN: 1763-23-1, DTXSID3031864
|
529: Xenobiotic binding to peroxisome proliferator-activated receptors (PPARs) causes dysregulation of lipid metabolism leading to liver steatosis
|
| 175 |
PERFLUOROOCTANOIC ACID
|
|
2 AOPs
|
| 104 |
Permethrin
|
-
Permethrin, CAS-RN: 52645-53-1, DTXSID8022292
|
None
|
| 585 |
PF-06651600 (CAS No:1792180-81-4),
|
|
315: Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response
|
| 587 |
PF-06651600 (CAS No:1792180-81-4), RB1
|
|
None
|
| 579 |
PF915275
|
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 46 |
Phenanthrene
|
-
Phenanthrene, CAS-RN: 85-01-8, DTXSID6024254
|
None
|
| 433 |
Phenethyl isothiocyanate
|
-
Phenethyl isothiocyanate, CAS-RN: 2257-09-2, DTXSID5021120
|
None
|
| 133 |
Phenobarbital
|
-
Phenobarbital, CAS-RN: 50-06-6, DTXSID5021122
|
2 AOPs
|
| 182 |
Phenylbutazone
|
-
4-Butyl-1,2-diphenyl-3,5-Pyrazolidinedione, CAS-RN: 50-33-9, DTXSID9021136
|
177: Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
|
| 96 |
Phenytoin
|
|
None
|
| 499 |
Photoactivated chemicals
|
|
None
|
| 440 |
Photoreactive chemicals
|
|
282: Adverse outcome pathway on photochemical toxicity initiated by light exposure
|
| 260 |
Phthalates
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 647 |
physical inactivity
|
|
403: combined unhealthy lifestyle factors leading to metabolic syndrome
|